CNPLE geriatric questions for Canadian nurse practitioners

Canada's aging population means that geriatric primary care is a central NP practice domain. Canadian NPs in community settings routinely assess frailty, manage multimorbidity, review complex medication regimens, coordinate dementia care, counsel on advance care planning, and support patients and families through end-of-life decisions. The CNPLE tests these competencies as part of the lifespan framework that underpins the national single NP classification model.

Geriatric scenarios on the CNPLE do not present single-system pathology in isolation. They present the clinical complexity of the real older adult: a patient with diabetes, hypertension, moderate dementia, and recent falls who presents with increasing confusion. The NP must systematically assess each contributing factor, manage polypharmacy safely, address functional decline, and engage appropriate community supports — all within primary care scope.

Frailty is not synonymous with age — it is a clinical syndrome of reduced physiological reserve that increases vulnerability to adverse outcomes. The Rockwood Clinical Frailty Scale (CFS) provides a practical clinical tool used widely in Canadian primary care, rating patients from Very Fit (1) to Terminally Ill (9). CNPLE-aligned preparation covers how frailty staging informs treatment decisions: a CFS 6–7 patient with a new atrial fibrillation diagnosis has a different anticoagulation risk-benefit calculus than a robust 80-year-old.

The comprehensive geriatric assessment (CGA) concept informs CNPLE scenarios: systematic evaluation of functional status (ADLs, IADLs), cognitive function (MMSE, MoCA — knowing which tool to use and how to interpret the result), mood (GDS, PHQ-9 adapted for older adults), medication burden, social supports, and home safety. The NP does not need to memorise scoring algorithms verbatim; the CNPLE tests whether the candidate understands what the assessment reveals and how it changes management.

Polypharmacy — typically defined as five or more concurrent medications — is ubiquitous in older Canadian primary care patients and carries compounding risks: adverse drug reactions, drug-disease interactions, drug-drug interactions, adherence challenges, and falls risk. The CNPLE tests the NP's ability to critically review a medication list and identify candidates for deprescribing.

The Beers Criteria (American Geriatrics Society) and STOPP/START (European) tools provide systematic frameworks for identifying potentially inappropriate medications in older adults — anticholinergic burden (TCAs, first-generation antihistamines, bladder agents in a patient with dementia), benzodiazepine use (falls risk, dependence, cognitive impairment), NSAIDs (renal function, GI risk, fluid retention in heart failure), and proton pump inhibitors at doses or durations exceeding indication. CNPLE-aligned preparation includes scenario-based practice applying these frameworks rather than list memorisation.

Dementia management in Canadian primary care NP practice includes early identification (cognitive screening triggers, appropriate investigation to rule out reversible causes), pharmacological management (cholinesterase inhibitors — who benefits, realistic expectations, when to discontinue), behavioural and psychological symptoms of dementia (non-pharmacological first-line, antipsychotic risks in older adults with dementia), and advance care planning initiated early while the patient retains decision-making capacity.

Goals-of-care conversations are a core NP professional competency — knowing how to introduce advance care planning, use tools like the Serious Illness Conversation Guide, and document substitute decision-maker designation and treatment preferences in the patient's record. Medical assistance in dying (MAID) competency for the CNPLE focuses on the regulatory framework, eligibility criteria assessment, and professional obligations around referral — not procedural technique, which is a separate scope consideration by province.